SHINE Medical Technologies is a nuclear technology company committed to improving the lives of patients around the world. The company is focused initially on the commercialization of medical isotopes. Molybdenum-99 is a diagnostic isotope used to diagnose heart disease, cancer and other diseases. Lutetium-177 is a therapeutic isotope could revolutionize cancer treatment. SHINE’s unique expertise and experience have created isotope production processes that not only will deliver products that help physicians and patients, they will solve critical supply chain problems in the United States, Europe and other global markets. SHINE’s nuclear technology is part of its long-term growth strategy to solve some of humanity’s biggest problems, including the generation of carbon-free energy from nuclear fusion. For more information, please visit our website at www.shinemed.com.